Literature DB >> 33845018

Classification Criteria for Vogt-Koyanagi-Harada Disease.

.   

Abstract

PURPOSE: To determine classification criteria for Vogt-Koyanagi-Harada (VKH) disease.
DESIGN: Machine learning of cases with VKH disease and 5 other panuveitides.
METHODS: Cases of panuveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used on the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the panuveitides. The resulting criteria were evaluated on the validation set.
RESULTS: One thousand twelve cases of panuveitides, including 156 cases of early-stage VKH and 103 cases of late-stage VKH, were evaluated. Overall accuracy for panuveitides was 96.3% in the training set and 94.0% in the validation set (95% confidence interval 89.0, 96.8). Key criteria for early-stage VKH included the following: (1) exudative retinal detachment with characteristic appearance on fluorescein angiogram or optical coherence tomography or (2) panuveitis with ≥2 of 5 neurologic symptoms/signs. Key criteria for late-stage VKH included history of early-stage VKH and either (1) sunset glow fundus or (2) uveitis and ≥1 of 3 cutaneous signs. The misclassification rates in the learning and validation sets for early-stage VKH were 8.0% and 7.7%, respectively, and for late-stage VKH 1.0% and 12%, respectively.
CONCLUSIONS: The criteria for VKH had a reasonably low misclassification rate and seemed to perform sufficiently well for use in clinical and translational research.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33845018      PMCID: PMC9073858          DOI: 10.1016/j.ajo.2021.03.036

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.488


  25 in total

1.  A significant association of HLA-DPB1*0501 with Vogt-Koyanagi-Harada's disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405.

Authors:  Y Shindo; S Ohno; S Nakamura; K Onoé; H Inoko
Journal:  Tissue Antigens       Date:  1996-04

Review 2.  Vogt-Koyanagi-Harada disease.

Authors:  Ghazala A Datoo O'Keefe; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2016-05-27       Impact factor: 6.048

3.  Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease.

Authors:  Peizeng Yang; Yuanyuan Zhong; Liping Du; Wei Chi; Ling Chen; Rui Zhang; Meifen Zhang; Hong Wang; Hong Lu; Liu Yang; Wenjuan Zhuang; Yan Yang; Lin Xing; Lei Feng; Zhengxuan Jiang; Xiaomin Zhang; Yuqin Wang; Hui Zhong; Liqiong Jiang; Changlin Zhao; Fuzhen Li; Shuang Cao; Xiaoli Liu; Xuan Chen; Yanyun Shi; Weizhong Zhao; Aize Kijlstra
Journal:  JAMA Ophthalmol       Date:  2018-09-01       Impact factor: 7.389

4.  The 2009 prospective multi-center epidemiologic survey of uveitis in Japan.

Authors:  Nobuyuki Ohguro; Koh-Hei Sonoda; Masaru Takeuchi; Miyo Matsumura; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2012-07-03       Impact factor: 2.447

5.  Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.

Authors:  Makiko Nakayama; Hiroshi Keino; Annabelle A Okada; Takayo Watanabe; Wakako Taki; Makoto Inoue; Akito Hirakata
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

6.  Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.

Authors:  T Y Y Lai; R P S Chan; C K M Chan; D S C Lam
Journal:  Eye (Lond)       Date:  2008-03-28       Impact factor: 3.775

7.  Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.

Authors:  Soon-Phaik Chee; Aliza Jap; Kristine Bacsal
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

8.  Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease.

Authors:  Narsing A Rao; Amod Gupta; Laurie Dustin; Soon Phaik Chee; Annabelle A Okada; Moncef Khairallah; Bahram Bodaghi; Phuc Lehoang; Massimo Accorinti; Manabu Mochizuki; Tisha Prabriputaloong; Russell W Read
Journal:  Ophthalmology       Date:  2009-12-24       Impact factor: 12.079

Review 9.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

10.  Development of Classification Criteria for the Uveitides.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-20       Impact factor: 5.488

View more
  3 in total

Review 1.  [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group].

Authors:  Arnd Heiligenhaus; Kai Rothaus; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-08-30       Impact factor: 1.059

2.  Objective evaluation of choroidal melanin loss in patients with Vogt-Koyanagi-Harada disease using polarization-sensitive optical coherence tomography.

Authors:  Masahiro Miura; Shuichi Makita; Yoshiaki Yasuno; Shinnosuke Azuma; Toshihiro Mino; Tatsuo Yamaguchi; Takuya Iwasaki; Rei Nemoto; Hiroyuki Shimizu; Hiroshi Goto
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

3.  Recurrent Vogt-Koyanagi-Harada disease presenting with diffuse orbital inflammation.

Authors:  Brandon Fram; Andrew Fernandez; Huzaefah Syed; Vikram Brar
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.